MyFinsight
Home
Blog
About
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
177.88%
Quick Ratio
158.02%
Cash Ratio
72.61%
Unit: Thousand (K) dollars
Assets Breakdown
Intangible assets, net
Goodwill
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in capital
Long-term debt, less current por...
Retained earnings
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
1,619,800
1,844,300
1,391,899
1,326,070
Investments
580,000
1,030,000
1,050,000
720,000
Accounts receivable, net of allowances
880,900
836,300
830,747
764,364
Inventories
443,000
437,500
416,962
483,111
Prepaid expenses
200,000
149,700
152,481
146,892
Other current assets
244,500
285,300
323,954
315,441
Total current assets
3,968,200
4,583,100
4,166,043
3,755,878
Property, plant and equipment, net
212,000
203,100
199,857
188,913
Operating lease assets
52,100
55,800
58,880
61,204
Intangible assets, net
4,029,500
4,203,800
4,429,510
4,565,737
Goodwill
1,799,800
1,805,000
1,829,340
1,827,483
Deferred tax assets, net
926,400
907,000
869,130
846,168
Deferred financing costs
6,600
7,100
7,550
8,034
Other non-current assets
86,300
94,700
99,030
103,068
Total assets
11,080,900
11,859,600
11,659,340
11,356,485
Accounts payable
128,500
100,000
122,061
152,227
Accrued liabilities
1,030,000
1,022,400
1,034,170
1,001,556
Current portion of long-term debt
1,016,400
1,030,500
1,029,903
1,029,179
Income taxes payable
55,900
93,700
56,387
91,140
Total current liabilities
2,230,800
2,246,600
2,242,521
2,274,102
Long-term debt, less current portion
3,335,000
4,324,200
4,328,354
4,331,982
Operating lease liabilities, less current portion
43,600
47,300
50,892
53,426
Deferred tax liabilities, net
528,900
547,700
594,470
629,033
Other non-current liabilities
140,900
161,500
124,519
108,912
Ordinary shares
0
0
6
6
Non-voting euro deferred shares
100
100
55
55
Capital redemption reserve
500
500
473
473
Additional paid-in capital
4,331,600
4,243,500
4,240,472
4,085,669
Accumulated other comprehensive loss
-662,500
-651,000
-568,598
-569,898
Retained earnings
1,132,000
939,200
646,176
442,725
Total shareholders equity
4,801,700
4,532,300
4,318,584
3,959,030
Total liabilities and shareholders equity
11,080,900
11,859,600
11,659,340
11,356,485
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$1,619,800K
(36.13%↑ Y/Y)
Accounts receivable, net
of allowances
$880,900K
(23.37%↑ Y/Y)
Investments
$580,000K
(20.83%↑ Y/Y)
Inventories
$443,000K
(-12.28%↓ Y/Y)
Other current assets
$244,500K
(-17.83%↓ Y/Y)
Prepaid expenses
$200,000K
(21.95%↑ Y/Y)
Intangible assets, net
$4,029,500K
(-15.51%↓ Y/Y)
Total current assets
$3,968,200K
(18.44%↑ Y/Y)
Goodwill
$1,799,800K
(-2.40%↓ Y/Y)
Deferred tax assets, net
$926,400K
(53.66%↑ Y/Y)
Property, plant and
equipment, net
$212,000K
(14.61%↑ Y/Y)
Other non-current
assets
$86,300K
(-28.84%↓ Y/Y)
Operating lease assets
$52,100K
(-17.41%↓ Y/Y)
Deferred financing costs
$6,600K
(-22.50%↓ Y/Y)
Total assets
$11,080,900K
(1.25%↑ Y/Y)
Total liabilities and
shareholders equity
$11,080,900K
(1.25%↑ Y/Y)
Total shareholders
equity
$4,801,700K
(29.55%↑ Y/Y)
Long-term debt, less
current portion
$3,335,000K
(-23.08%↓ Y/Y)
Total current
liabilities
$2,230,800K
(7.71%↑ Y/Y)
Deferred tax
liabilities, net
$528,900K
(-22.46%↓ Y/Y)
Other non-current
liabilities
$140,900K
(50.32%↑ Y/Y)
Operating lease
liabilities, less current...
$43,600K
(-20.88%↓ Y/Y)
Accumulated other
comprehensive loss
-$662,500K
(-36.38%↓ Y/Y)
Additional paid-in capital
$4,331,600K
(8.28%↑ Y/Y)
Retained earnings
$1,132,000K
(491.70%↑ Y/Y)
Accrued liabilities
$1,030,000K
(17.74%↑ Y/Y)
Current portion of
long-term debt
$1,016,400K
(-1.17%↓ Y/Y)
Accounts payable
$128,500K
(43.79%↑ Y/Y)
Income taxes payable
$55,900K
(-28.84%↓ Y/Y)
Capital redemption
reserve
$500K
(5.71%↑ Y/Y)
Non-voting euro deferred
shares
$100K
(81.82%↑ Y/Y)
Buy us a coffee